Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia

British Journal of Haematology

Volumn 164, Issue 1, 2014, Pages 142-145

  Shiba, Norio ^a,b   Funato, Michinori ^c   Ohki, Kentaro ^a   Park, Myoung ja ^a   Mizushima, Yasuhiro ^d   Adachi, Souichi ^e   Kobayashi, Masao ^f   Kinoshita, Akitoshi ^g   Sotomatsu, Manabu ^a   Arakawa, Hirokazu ^b   Tawa, Akio ^h   Horibe, Keizo ⁱ   Tsukimoto, Ichiro ^j   Hayashi, Yasuhide ^a  

^a Gumna Children S Medical Center   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d KYOTO KATSURA HOSPITAL   (Japan)

^e KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f HIROSHIMA UNIVERSITY   (Japan)

^g ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h OSAKA NATIONAL HOSPITAL   (Japan)

ⁱ NATIONAL HOSPITAL ORGANIZATION   (Japan)

^j TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Acute promyelocytic leukaemia; Germline mutation; Paediatric acute myeloid leukaemia

Indexed keywords

ANTINEOPLASTIC AGENT; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD135 ANTIGEN; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR GATA 2;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; CANCER PROGNOSIS; CANCER SURVIVAL; CEBPA GENE; CHILD; CHILDHOOD CANCER; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 11; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FLT3 GENE; GATA2 GENE; GENE DUPLICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; KIT GENE; LETTER; LEUKEMIA REMISSION; LEUKEMOGENESIS; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NPM1 GENE; ONCOGENE K RAS; ONCOGENE N RAS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

ACUTE PROMYELOCYTIC LEUKAEMIA; CEBPA; GATA2; GERMLINE MUTATION; PAEDIATRIC ACUTE MYELOID LEUKAEMIA;

ADOLESCENT; AMINO ACID SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; GATA2 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MOLECULAR SEQUENCE DATA;

EID: 84889588564     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12559     Document Type: Letter

References (10)

1. Böhm, M., Locke, W.J., Sutherland, R.L., Kench, J.G. & Henshall, S.M. (2009) A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes. Oncogene, 28, 3847-3856.
2. Green, C.L., Tawana, K., Hills, R.K., Bödör, C., Fitzgibbon, J., Inglott, S., Ancliff, P., Burnett, A.K., Linch, D.C. & Gale, R.E. (2013) GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations. British Journal of Haematology, 161, 701-705.
3. Greif, P.A., Dufour, A., Konstandin, N.P., Ksienzyk, B., Zellmeier, E., Tizazu, B., Sturm, J., Benthaus, T., Herold, T., Yaghmaie, M., Dörge, P., Hopfner, K.P., Hauser, A., Graf, A., Krebs, S., Blum, H., Kakadia, P.M., Schneider, S., Hoster, E., Schneider, F., Stanulla, M., Braess, J., Sauerland, M.C., Berdel, W.E., Büchner, T., Woermann, B.J., Hiddemann, W., Spiekermann, K. & Bohlander, S.K. (2012) GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood, 120, 395-403.
4. Hahn, C.N., Chong, C.E., Carmichael, C.L., Wilkins, E.J., Brautigan, P.J., Li, X.C., Babic, M., Lin, M., Carmagnac, A., Lee, Y.K., Kok, C.H., Gagliardi, L., Friend, K.L., Ekert, P.G., Butcher, C.M., Brown, A.L., Lewis, I.D., To, L.B., Timms, A.E., Storek, J., Moore, S., Altree, M., Escher, R., Bardy, P.G., Suthers, G.K., D'Andrea, R.J., Horwitz, M.S. & Scott, H.S. (2011) Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nature Genetics, 43, 1012-1017.
5. Hsu, A.P., Sampaio, E.P., Khan, J., Calvo, K.R., Lemieux, J.E., Patel, S.Y., Frucht, D.M., Vinh, D.C., Auth, R.D., Freeman, A.F., Olivier, K.N., Uzel, G., Zerbe, C.S., Spalding, C., Pittaluga, S., Raffeld, M., Kuhns, D.B., Ding, L., Paulson, M.L., Marciano, B.E., Gea-Banacloche, J.C., Orange, J.S., Cuellar-Rodriguez, J., Hickstein, D.D. & Holland, S.M. (2011) Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood, 118, 2653-2655.
6. Kumar, M.S., Hancock, D.C., Molina-Arcas, M., Steckel, M., East, P., Diefenbacher, M., Armenteros-Monterroso, E., Lassailly, F., Matthews, N., Nye, E., Stamp, G., Behrens, A. & Downward, J. (2012) The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. Cell, 149, 642-655.
7. Luesink, M., Hollink, I.H., van der Velden, V.H., Knops, R.H., Boezeman, J.B., de Haas, V., Trka, J., Baruchel, A., Reinhardt, D., van der Reijden, B.A., van den Heuvel-Eibrink, M.M., Zwaan, C.M. & Jansen, J.H. (2012) High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia. Blood, 120, 2064-2075.
8. Shimada, A., Taki, T., Tabuchi, K., Tawa, A., Horibe, K., Tsuchida, M., Hanada, R., Tsukimoto, I. & Hayashi, Y. (2006) KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group. Blood, 107, 1806-1809.
9. Tsuzuki, S., Towatari, M., Saito, H. & Enver, T. (2000) Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein. Molecular and Cellular Biology, 20, 6276-6286.
10. Zhang, S.J., Ma, L.Y., Huang, Q.H., Li, G., Gu, B.W., Gao, X.D., Shi, J.Y., Wang, Y.Y., Gao, L., Cai, X., Ren, R.B., Zhu, J., Chen, Z. & Chen, S.J. (2008) Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proceedings of the National Academy of Sciences, 105, 2076-2081.